572 related articles for article (PubMed ID: 20674732)
1. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
Shegokar R; Müller RH
Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
[TBL] [Abstract][Full Text] [Related]
2. State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.
Müller RH; Gohla S; Keck CM
Eur J Pharm Biopharm; 2011 May; 78(1):1-9. PubMed ID: 21266197
[TBL] [Abstract][Full Text] [Related]
3. Drug nanocrystals in the commercial pharmaceutical development process.
Möschwitzer JP
Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
[TBL] [Abstract][Full Text] [Related]
4. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
Muller RH; Keck CM
J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
[TBL] [Abstract][Full Text] [Related]
5. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.
Pawar VK; Singh Y; Meher JG; Gupta S; Chourasia MK
J Control Release; 2014 Jun; 183():51-66. PubMed ID: 24667572
[TBL] [Abstract][Full Text] [Related]
6. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.
Van Eerdenbrugh B; Van den Mooter G; Augustijns P
Int J Pharm; 2008 Nov; 364(1):64-75. PubMed ID: 18721869
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in intravenous delivery of poorly water-soluble compounds.
Shi Y; Porter W; Merdan T; Li LC
Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
[TBL] [Abstract][Full Text] [Related]
8. smartPearls - Novel physically stable amorphous delivery system for poorly soluble dermal actives.
Müller RH; Hespeler D; Jin N; Pyo SM
Int J Pharm; 2019 Jan; 555():314-321. PubMed ID: 30439490
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical nanocrystals: production by wet milling and applications.
Malamatari M; Taylor KMG; Malamataris S; Douroumis D; Kachrimanis K
Drug Discov Today; 2018 Mar; 23(3):534-547. PubMed ID: 29326082
[TBL] [Abstract][Full Text] [Related]
10. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
Merisko-Liversidge E; Liversidge GG
Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
[TBL] [Abstract][Full Text] [Related]
11. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
12. Nanosuspensions of poorly water soluble drugs prepared by top-down technologies.
Zhang X; Li LC; Mao S
Curr Pharm Des; 2014; 20(3):388-407. PubMed ID: 23651400
[TBL] [Abstract][Full Text] [Related]
13. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
Karanth H; Shenoy VS; Murthy RR
AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
[TBL] [Abstract][Full Text] [Related]
14. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies.
Du J; Li X; Zhao H; Zhou Y; Wang L; Tian S; Wang Y
Int J Pharm; 2015 Nov; 495(2):738-49. PubMed ID: 26383838
[TBL] [Abstract][Full Text] [Related]
15. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
Bunjes H
J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
[TBL] [Abstract][Full Text] [Related]
17. Drug nanocrystals: In vivo performances.
Gao L; Liu G; Ma J; Wang X; Zhou L; Li X
J Control Release; 2012 Jun; 160(3):418-30. PubMed ID: 22465393
[TBL] [Abstract][Full Text] [Related]
18. Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.
Lai F; Schlich M; Pireddu R; Corrias F; Fadda AM; Sinico C
Curr Pharm Des; 2015; 21(42):6089-103. PubMed ID: 26503149
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
20. Nanocrystals: An Overview of Fabrication, Characterization and Therapeutic Applications in Drug Delivery.
Pardhi VP; Verma T; Flora SJS; Chandasana H; Shukla R
Curr Pharm Des; 2018; 24(43):5129-5146. PubMed ID: 30767737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
